NPI: 1598719346 · EUCLID, OH 44119 · General Acute Care Hospital · NPI assigned 05/19/2006
Authorized official LARAWAY, DENNIS controls 20+ related entities in our dataset. Read more
| Authorized Official | LARAWAY, DENNIS (EXECUTIVE VP CHIEF FINANCE OFFICER) |
| NPI Enumeration Date | 05/19/2006 |
Other providers sharing the same authorized official: LARAWAY, DENNIS
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 102,423 | $2.86M |
| 2019 | 93,203 | $2.91M |
| 2020 | 68,724 | $4.00M |
| 2021 | 96,341 | $5.57M |
| 2022 | 92,203 | $5.03M |
| 2023 | 281,622 | $12.43M |
| 2024 | 208,785 | $7.87M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 59,199 | 55,709 | $7.31M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 50,229 | 46,170 | $6.70M |
| 96361 | Intravenous infusion, hydration; each additional hour | 18,040 | 13,809 | $6.17M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 44,287 | 39,053 | $6.13M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 10,020 | 8,769 | $1.39M |
| 70450 | Computed tomography, head or brain; without contrast material | 4,333 | 3,642 | $1.24M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 6,658 | 6,092 | $1.05M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 12,875 | 10,715 | $989K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3,063 | 2,573 | $911K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 12,086 | 4,950 | $906K |
| G0378 | Hospital observation service, per hour | 13,807 | 6,111 | $813K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4,286 | 3,990 | $539K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3,691 | 2,653 | $510K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 2,086 | 1,097 | $420K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 3,173 | 2,396 | $408K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,309 | 1,101 | $389K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2,060 | 1,813 | $386K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1,263 | 1,061 | $348K |
| 80053 | Comprehensive metabolic panel | 53,980 | 45,173 | $294K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 6,248 | 5,951 | $272K |
| 87631 | 1,338 | 1,254 | $215K | |
| 81513 | 1,089 | 964 | $171K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 633 | 536 | $161K |
| 93975 | 986 | 861 | $128K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 13,962 | 8,517 | $110K |
| 70491 | 268 | 223 | $98K | |
| 70498 | 329 | 268 | $91K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 6,673 | 5,330 | $90K |
| 97535 | Self-care/home management training, each 15 minutes | 2,865 | 2,132 | $86K |
| 97161 | 2,508 | 2,147 | $83K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 1,851 | 683 | $71K |
| 12001 | 358 | 321 | $65K | |
| 10060 | 331 | 278 | $64K | |
| 93971 | 841 | 722 | $62K | |
| 71250 | 674 | 603 | $60K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2,014 | 989 | $55K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 382 | 276 | $52K |
| 82805 | 1,352 | 1,049 | $48K | |
| 97116 | 1,953 | 995 | $48K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 7,744 | 7,187 | $47K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 28,119 | 23,146 | $47K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 544 | 443 | $45K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 53,179 | 44,204 | $43K |
| 97165 | 890 | 734 | $41K | |
| 84484 | 16,874 | 10,785 | $41K | |
| 36415 | Collection of venous blood by venipuncture | 70,681 | 46,688 | $40K |
| 71046 | Radiologic examination, chest; 2 views | 5,485 | 5,021 | $40K |
| 64493 | 108 | 86 | $39K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 295 | 281 | $39K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 26,884 | 22,655 | $36K |
| 85027 | 16,012 | 11,147 | $35K | |
| 93970 | 238 | 205 | $35K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,500 | 1,288 | $34K |
| 72131 | 414 | 359 | $34K | |
| 86850 | 1,411 | 1,216 | $33K | |
| 76830 | Ultrasound, transvaginal | 690 | 607 | $33K |
| 71045 | Radiologic examination, chest; single view | 15,138 | 13,059 | $33K |
| 97802 | 590 | 462 | $33K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 546 | 196 | $32K |
| J1756 | Injection, iron sucrose, 1 mg | 1,267 | 430 | $30K |
| 99222 | Initial hospital care, per day, moderate complexity | 874 | 802 | $27K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 980 | 575 | $26K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 180 | 141 | $25K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 80 | 76 | $25K |
| 70486 | 632 | 546 | $24K | |
| 93799 | 4,988 | 1,940 | $24K | |
| 96127 | 296 | 224 | $23K | |
| 84443 | Thyroid stimulating hormone (TSH) | 2,240 | 1,929 | $23K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 616 | 593 | $23K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 52 | 51 | $22K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,019 | 952 | $21K |
| 80061 | Lipid panel | 1,744 | 1,494 | $20K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 908 | 766 | $18K |
| 86900 | 1,430 | 1,219 | $17K | |
| 82962 | 12,354 | 4,051 | $17K | |
| 81001 | 47,709 | 43,136 | $16K | |
| 96367 | 528 | 378 | $16K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,381 | 1,156 | $15K |
| 99215 | Prolong outpt/office vis | 379 | 356 | $15K |
| 12011 | 78 | 62 | $15K | |
| 80069 | 1,401 | 1,170 | $14K | |
| 82728 | 1,202 | 1,084 | $14K | |
| 86780 | 1,741 | 1,535 | $14K | |
| 64483 | 42 | 36 | $13K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 30 | 25 | $13K |
| 99221 | 529 | 497 | $12K | |
| 70496 | 389 | 315 | $12K | |
| 85610 | 7,213 | 5,054 | $12K | |
| 83735 | 20,292 | 16,193 | $12K | |
| 84702 | 1,428 | 1,087 | $11K | |
| 90715 | 748 | 588 | $11K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 7,767 | 7,209 | $11K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 914 | 813 | $11K |
| 72100 | 1,012 | 849 | $10K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 949 | 802 | $9K |
| 73564 | 1,044 | 901 | $9K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 10,370 | 8,042 | $9K |
| 87340 | 509 | 445 | $9K | |
| 73030 | 1,102 | 953 | $9K | |
| 83540 | 1,303 | 1,166 | $9K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 5,019 | 4,493 | $8K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 227 | 200 | $8K |
| 83970 | 393 | 326 | $8K | |
| 82607 | 582 | 477 | $8K | |
| 76857 | 744 | 655 | $8K | |
| 73610 | 1,252 | 1,115 | $7K | |
| 76801 | 558 | 483 | $7K | |
| 86140 | 2,235 | 1,829 | $7K | |
| 96376 | 3,999 | 2,029 | $7K | |
| 83550 | 1,294 | 1,156 | $7K | |
| 73630 | 1,374 | 1,252 | $7K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 421 | 380 | $7K |
| 62323 | 14 | 12 | $6K | |
| 86803 | 320 | 287 | $6K | |
| 86901 | 1,430 | 1,219 | $6K | |
| 99232 | Subsequent hospital care, per day, moderate complexity | 370 | 348 | $6K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 794 | 575 | $6K |
| 73130 | 1,197 | 1,022 | $6K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 4,562 | 4,013 | $6K |
| 74018 | 474 | 384 | $6K | |
| 73502 | 775 | 647 | $6K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 14 | 12 | $6K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 26 | 24 | $6K |
| 84439 | 338 | 306 | $5K | |
| 83880 | 2,690 | 2,182 | $5K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 8,235 | 6,017 | $5K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 597 | 516 | $5K |
| 82570 | 505 | 454 | $5K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 3,900 | 3,437 | $5K |
| 12002 | 24 | 19 | $4K | |
| 74183 | 12 | 12 | $4K | |
| 36430 | 17 | 12 | $4K | |
| 97162 | 100 | 84 | $4K | |
| 93798 | 89 | 12 | $4K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3,218 | 2,862 | $4K |
| 73560 | 627 | 533 | $4K | |
| 82077 | 3,691 | 2,781 | $3K | |
| G0257 | Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility | 22 | 14 | $3K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 17 | 17 | $3K |
| 97113 | 80 | 39 | $3K | |
| 99218 | 150 | 143 | $3K | |
| 80320 | 300 | 273 | $3K | |
| 84100 | 903 | 594 | $3K | |
| 82553 | 637 | 468 | $3K | |
| 73110 | 616 | 545 | $3K | |
| 83690 | 9,663 | 8,123 | $3K | |
| 82550 | 5,318 | 4,291 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 883 | 707 | $3K |
| A9270 | Non-covered item or service | 2,605 | 1,276 | $2K |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | 77 | 31 | $2K |
| 80076 | 233 | 178 | $2K | |
| 99224 | 277 | 274 | $2K | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 844 | 407 | $2K |
| 76770 | 16 | 16 | $2K | |
| 87077 | 1,501 | 1,282 | $2K | |
| 97810 | 45 | 26 | $2K | |
| 99223 | Prolong inpt eval add15 m | 43 | 41 | $2K |
| 87430 | 2,039 | 1,954 | $1K | |
| 81025 | 28,075 | 25,691 | $1K | |
| 82043 | 206 | 185 | $1K | |
| 96368 | 80 | 53 | $1K | |
| 76536 | 14 | 12 | $1K | |
| 98927 | 36 | 26 | $1K | |
| 73590 | 385 | 346 | $1K | |
| 83605 | 2,753 | 1,920 | $1K | |
| 86703 | 1,217 | 1,072 | $1K | |
| 82330 | 1,478 | 1,084 | $1K | |
| 87481 | 992 | 873 | $1K | |
| 73140 | 223 | 199 | $1K | |
| 90686 | 47 | 43 | $1K | |
| 73700 | 14 | 12 | $1K | |
| 85730 | 1,184 | 888 | $1K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 2,749 | 1,800 | $897.84 |
| 84550 | 320 | 272 | $805.01 | |
| 87205 | 1,478 | 1,385 | $796.92 | |
| 83874 | 64 | 56 | $775.69 | |
| 85379 | 2,108 | 1,781 | $768.31 | |
| 87186 | 1,166 | 986 | $730.66 | |
| 99152 | 276 | 219 | $719.72 | |
| 85018 | 1,419 | 1,109 | $716.84 | |
| 71101 | 137 | 122 | $710.30 | |
| 80197 | 34 | 12 | $666.24 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 1,199 | 518 | $646.84 |
| 84132 | 1,627 | 1,287 | $637.48 | |
| 85652 | 191 | 162 | $602.97 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 71 | 65 | $601.33 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 12 | 12 | $585.92 |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 126 | 112 | $540.46 |
| J1815 | Injection, insulin, per 5 units | 100 | 75 | $532.43 |
| 82435 | 1,237 | 970 | $516.17 | |
| C9113 | Injection, pantoprazole sodium, per vial | 452 | 223 | $503.13 |
| 64494 | 104 | 85 | $501.98 | |
| 82375 | 1,280 | 995 | $498.14 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 14,723 | 12,781 | $474.68 |
| 00731 | 99 | 76 | $447.26 | |
| 94760 | 2,194 | 1,236 | $436.53 | |
| 72040 | 38 | 29 | $426.44 | |
| 73080 | 226 | 200 | $395.10 | |
| 87070 | 278 | 225 | $364.57 | |
| 87808 | 1,057 | 1,025 | $359.55 | |
| 80177 | 117 | 96 | $349.90 | |
| 82010 | 742 | 574 | $308.88 | |
| J1644 | Injection, heparin sodium, per 1000 units | 1,336 | 484 | $307.08 |
| 84481 | 32 | 27 | $306.85 | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 12 | 12 | $291.53 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 767 | 744 | $288.85 |
| 87040 | 814 | 614 | $288.74 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 944 | 651 | $286.28 |
| 99225 | 28 | 28 | $273.81 | |
| 84295 | 1,352 | 1,053 | $269.21 | |
| 97811 | 24 | 14 | $248.59 | |
| 76870 | 15 | 14 | $244.65 | |
| 73090 | 128 | 115 | $244.42 | |
| 84703 | 963 | 817 | $236.32 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 334 | 264 | $231.12 |
| 83050 | 991 | 775 | $208.70 | |
| 82150 | 282 | 253 | $208.19 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 2,157 | 1,798 | $197.21 |
| J1790 | Injection, droperidol, up to 5 mg | 1,425 | 1,058 | $145.85 |
| 86706 | 30 | 27 | $143.85 | |
| J2060 | Injection, lorazepam, 2 mg | 1,289 | 881 | $120.60 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 452 | 356 | $119.61 |
| J1940 | Injection, furosemide, up to 20 mg | 363 | 218 | $119.57 |
| J1953 | Injection, levetiracetam, 10 mg | 20 | 14 | $119.50 |
| 82272 | 95 | 75 | $116.51 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 5,618 | 2,798 | $112.19 |
| 82746 | 44 | 36 | $107.68 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 3,602 | 2,621 | $107.59 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 2,489 | 1,807 | $107.35 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 7,706 | 5,923 | $99.65 |
| J2704 | Injection, propofol, 10 mg | 1,572 | 1,147 | $88.70 |
| 86308 | 158 | 116 | $82.19 | |
| 80164 | 13 | 13 | $79.13 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 320 | 232 | $76.62 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 370 | 268 | $75.68 |
| J3480 | Injection, potassium chloride, per 2 meq | 625 | 443 | $68.24 |
| J3370 | Injection, vancomycin hcl, 500 mg | 117 | 59 | $66.35 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 180 | 164 | $63.45 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,217 | 936 | $59.64 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 5,795 | 4,857 | $53.08 |
| 72020 | 61 | 41 | $53.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,201 | 827 | $49.64 |
| 85045 | 45 | 24 | $46.97 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 2,792 | 2,098 | $42.01 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 1,088 | 794 | $40.47 |
| 82140 | 14 | 12 | $34.26 | |
| J3490 | Unclassified drugs | 21 | 16 | $25.76 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 864 | 676 | $19.98 |
| 87088 | 63 | 61 | $15.98 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 75 | 57 | $12.37 |
| J7030 | Infusion, normal saline solution , 1000 cc | 26 | 13 | $8.37 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 47 | 45 | $4.18 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 17 | 12 | $2.50 |
| J0690 | Injection, cefazolin sodium, 500 mg | 621 | 414 | $2.19 |
| J1171 | Injection, hydromorphone, 0.1 mg | 49 | 29 | $1.61 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 46 | 42 | $1.30 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 23 | 16 | $1.04 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 28 | 27 | $0.86 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 26 | 15 | $0.00 |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 195 | 151 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 12 | 12 | $0.00 |
| 87529 | 33 | 28 | $0.00 | |
| 51798 | 19 | 14 | $0.00 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 72 | 40 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 32 | 26 | $0.00 |
| 3074F | 40 | 39 | $0.00 | |
| 73552 | 13 | 13 | $0.00 | |
| J1630 | Injection, haloperidol, up to 5 mg | 17 | 16 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 51 | 43 | $0.00 |
| 3078F | 224 | 209 | $0.00 | |
| 3077F | 30 | 27 | $0.00 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 540 | 496 | $0.00 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 14 | 12 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 39 | 27 | $0.00 |
| 80179 | 14 | 12 | $0.00 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 13 | 13 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 152 | 125 | $0.00 |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 21 | 15 | $0.00 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 30 | 26 | $0.00 |
| 80143 | 15 | 13 | $0.00 | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 12 | 12 | $0.00 |
| 64495 | 51 | 45 | $0.00 |